- Home
- VRDN vs TILE Comparison
VRDN vs TILE Comparison
Compare VRDN & TILE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VRDN | TILE |
|---|---|---|
| Founded | 2006 | 1973 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Home Furnishings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.6B |
| IPO Year | 2014 | 1994 |
Fundamental Metrics
Financial Performance| Metric | VRDN | TILE |
|---|---|---|
| Price | $16.25 | $28.89 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 1 |
| Target Price | $35.46 | ★ $36.00 |
| AVG Volume (30 Days) | ★ 3.2M | 517.8K |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 0.29% |
| EPS Growth | N/A | ★ 32.43 |
| EPS | N/A | ★ 0.40 |
| Revenue | $5,706,000.00 | ★ $1,386,854,000.00 |
| Revenue This Year | $13.73 | $6.72 |
| Revenue Next Year | $279.00 | $5.61 |
| P/E Ratio | ★ N/A | $71.95 |
| Revenue Growth | N/A | ★ 5.41 |
| 52 Week Low | $13.18 | $20.01 |
| 52 Week High | $34.29 | $35.11 |
Technical Indicators
Market Signals| Indicator | VRDN | TILE |
|---|---|---|
| Relative Strength Index (RSI) | 45.59 | 52.05 |
| Support Level | $15.65 | $26.60 |
| Resistance Level | $18.05 | $28.89 |
| Average True Range (ATR) | 0.83 | 1.02 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 23.73 | 58.14 |
Price Performance
Historical ComparisonAbout VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. The company is developing two anti-IGF-1R product candidates, veligrotug for intravenous (IV) administration and elegrobart (formerly VRDN-003) for subcutaneous (SC) administration, to treat patients with TED. Our most advance program, veligrotug, is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of TED.
About TILE Interface Inc.
Interface Inc is engaged in the design, production, and sale of carpet tiles. It also provides Luxury Vinyl tiles and rubber flooring. The company mainly targets corporate and noncorporate office markets, including government, education, healthcare, hospitality, and retailers. Its geographical segments include the Americas, Europe, and Asia-Pacific. It has two operating and reportable segments- namely Americas (AMS) and Europe, Africa, Asia and Australia (collectively EAAA). Key revenue is generated from AMS segment. Its products include: ESD, Acoustic, Extreme Wear, and Quick Installation System (nTx).